Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories?
Kymera Therapeutics Inc. (NASDAQ:KYMR) is one of the best high-beta stocks to buy now. The company currently commands an optimistic outlook,…
Tag: Kymera
Kymera weakness a buying opportunity, says Stifel
Stifel analyst Alex Thompson is reiterating a Buy rating on Kymera Therapeutics (KYMR) following “a slate of updates,” including the…